You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行》匯豐研究:藥明康德(02359.HK)新訂單穩健增長 升目標價至124元
阿思達克 08-27 14:17
匯豐研究發表研究報告指,藥明康德(02359.HK)上半年業績表現強勁,非國際財務報告準則經調整淨利潤按年增長44%,勝預期,主要來自於經營效率提升,以及大型商業項目收入增長,推動毛利率擴張。匯豐研究對藥明康德增長前景及利潤率轉趨樂觀,認為新訂單穩健增長及利潤率持續改善,將成為公司短期潛在催化劑。 該行將藥明康德2025至2027年收入預測上調1%至3%,經調整淨利潤預測上調9%至11%,毛利率預測亦上調30至257個基點,預期集團加快產能全球化,可降低地緣政治不確定性風險,維持「買入」評級,目標價由83.7元上調至124元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account